Akebia Therapeutics, Inc. (AKBA)

$0.9 +2.88%

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-07 APPROXIMATE

Akebia Therapeutics, Inc. (AKBA) has a 21-report earnings history dating back to May 10, 2021. Its average absolute post-earnings move is ±12.05%, and 33.3% of those reactions were positive. Its largest post-earnings gain was +24.09% (Mar 14, 2024) and its largest decline was -22.23% (Mar 09, 2023). The next earnings report is predicted for 2026-08-07 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±12.05%

Positive %

33.3%

Negative %

66.7%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 07, 2026	☀ PRE	$1.14	$1.22	$1.19	399,960	-20.2%	open_in_new
Feb 26, 2026	☀ PRE	$1.47	$1.51	$1.32	5,001,600	+9.09%	open_in_new
Nov 10, 2025	☀ PRE	$1.73	$1.75	$1.67	16,762,300	-18.14%	open_in_new
Aug 07, 2025	☀ PRE	$3.21	$3.28	$3.01	14,792,700	-20.48%	open_in_new
May 08, 2025	☀ PRE	$2.77	$2.90	$2.62	10,590,600	+6.5%	open_in_new
Mar 13, 2025	☀ PRE	$1.80	$1.84	$1.69	9,611,800	-12.44%	open_in_new
Nov 07, 2024	☀ PRE	$1.74	$1.91	$1.86	4,754,600	-6.75%	open_in_new
Aug 08, 2024	☀ PRE	$1.16	$1.22	$1.19	2,226,600	+7.21%	open_in_new
May 09, 2024	☀ PRE	$1.11	$1.33	$1.33	8,226,800	-5%	open_in_new
Mar 14, 2024	☽ POST	$1.43	$1.43	$1.37	2,804,900	+24.09%	open_in_new
Nov 08, 2023	☀ PRE	$1.03	$1.07	$0.96	2,761,400	-11.93%	open_in_new
Aug 25, 2023	☀ PRE	$1.23	$1.32	$1.15	2,627,100	-8%	open_in_new
May 08, 2023	☀ PRE	$1.08	$1.08	$1.06	2,669,900	-2.75%	open_in_new
Mar 09, 2023	☀ PRE	$0.83	$0.86	$0.80	6,938,300	-22.23%	open_in_new
Nov 03, 2022	☽ POST	$0.26	$0.32	$0.28	3,505,300	-4.91%	open_in_new
Aug 04, 2022	☽ POST	$0.41	$0.42	$0.41	10,785,000	-3.66%	open_in_new
May 09, 2022	☽ POST	$0.37	$0.39	$0.34	9,317,200	+24.06%	open_in_new
Mar 01, 2022	☽ POST	$2.27	$2.27	$2.15	4,147,700	+13.95%	open_in_new
Nov 04, 2021	☀ PRE	$3.11	$3.30	$3.04	2,748,500	-8.98%	open_in_new
Aug 05, 2021	☀ PRE	$2.41	$2.87	$2.87	5,763,300	+15.73%	open_in_new
May 10, 2021	☀ PRE	$3.05	$3.07	$2.90	4,113,500	-7.05%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±12.05%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
10-Q	20260507	open_in_new SEC.gov
8-K	20260507	open_in_new SEC.gov
ARS	20260429	open_in_new SEC.gov
ARS	20260429	open_in_new SEC.gov
DEFA14A	20260428	open_in_new SEC.gov
DEF 14A	20260428	open_in_new SEC.gov
DEF 14A	20260428	open_in_new SEC.gov
DEFA14A	20260428	open_in_new SEC.gov
PRE 14A	20260415	open_in_new SEC.gov
4	20260403	open_in_new SEC.gov

Frequently asked about AKBA earnings

When does Akebia Therapeutics, Inc. report earnings next? expand_more

Akebia Therapeutics, Inc. (AKBA)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does AKBA stock move after earnings? expand_more

Over 21 reports, AKBA has moved an average of ±12.05% the session after earnings, closing higher 33.3% of the time.

What was AKBA's biggest post-earnings move? expand_more

AKBA's largest post-earnings gain on record was +24.09% on Mar 14, 2024, and its largest decline was -22.23% on Mar 09, 2023.

Where can I find Akebia Therapeutics, Inc.'s SEC filings? expand_more

All of Akebia Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.